Recent News

• 03.31.2026 - IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow
• 03.17.2026 - IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies
• 01.26.2026 - IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements
• 01.05.2026 - IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors
• 12.30.2025 - IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research
• 12.12.2025 - IM Cannabis Appoints Asi Levi as Chief Financial Officer

Recent Filings

• 03.31.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.31.2026 - EX-99.1 EX-99.1
• 03.30.2026 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.17.2026 - EX-99.1 EX-99.1
• 03.17.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.11.2026 - EFFECT Notice of Effectiveness
• 02.05.2026 - F-3 Registration statement by foreign private issuers
• 01.26.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.26.2026 - EX-99.1 EX-99.1
• 01.05.2026 - EX-99.1 EX-99.1